ATE71225T1 - Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten. - Google Patents

Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.

Info

Publication number
ATE71225T1
ATE71225T1 AT85850256T AT85850256T ATE71225T1 AT E71225 T1 ATE71225 T1 AT E71225T1 AT 85850256 T AT85850256 T AT 85850256T AT 85850256 T AT85850256 T AT 85850256T AT E71225 T1 ATE71225 T1 AT E71225T1
Authority
AT
Austria
Prior art keywords
sialosyllactotetraose
associated antigen
diagnosis
specific tumor
cancer diseases
Prior art date
Application number
AT85850256T
Other languages
English (en)
Inventor
Jan Roland Holmgren
Leif Gustav Lindholm
Lars Torvald Svennerholm
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Application granted granted Critical
Publication of ATE71225T1 publication Critical patent/ATE71225T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT85850256T 1984-08-28 1985-08-06 Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten. ATE71225T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8404283A SE455445B (sv) 1984-08-28 1984-08-28 Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik
EP85850256A EP0173663B1 (de) 1984-08-28 1985-08-06 Verwendung eines spezifischen tumorassoziierten Antigens, Sialosyllactotetraose, in Diagnose- oder Therapieverfahren bezüglich Krebskrankheiten

Publications (1)

Publication Number Publication Date
ATE71225T1 true ATE71225T1 (de) 1992-01-15

Family

ID=20356831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85850256T ATE71225T1 (de) 1984-08-28 1985-08-06 Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.

Country Status (5)

Country Link
EP (1) EP0173663B1 (de)
JP (1) JPH0690204B2 (de)
AT (1) ATE71225T1 (de)
DE (1) DE3585061D1 (de)
SE (1) SE455445B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287916A1 (de) * 1987-04-13 1988-10-26 Otsuka Pharmaceutical Co., Ltd. Immunoassay
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
EP0380084A3 (de) * 1989-01-27 1991-03-13 The Biomembrane Institute Methode zur Hemmung dvon Zell-Zell- und Zellsubstrat-Wechselwirkungen durch Blockierung der Kohlenhydrat-Kohlenhydrat-Wechselwirkungen
WO1990010708A1 (fr) * 1989-03-09 1990-09-20 The Sendai Institute Of Microbiology Anticorps monoclonal, et procede d'analyse, kit de reactif, procede de recherche et medicament utilisant ledit anticorps
EP1363643A2 (de) 2000-12-22 2003-11-26 Medlyte, Inc. Zusammensetzungen und methoden zur behandlung und vorbeugung von kardiovaskulären erkrankungen und zur identifizierung therapeutischer mittel
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US8796429B2 (en) 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US20080138334A1 (en) 2006-05-31 2008-06-12 Sabbadini Roger A Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
KR101581279B1 (ko) 2006-10-27 2015-12-31 엘파스, 인크. 스핑고신-1-포스페이트 결합을 위한 조성물 및 방법
WO2008055072A2 (en) 2006-10-27 2008-05-08 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
US8361465B2 (en) 2007-10-26 2013-01-29 Lpath, Inc. Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4471057A (en) * 1981-06-30 1984-09-11 The Wistar Institute Detection of colorectal carcinoma
CA1215331A (en) * 1983-03-04 1986-12-16 Tsann M. Chu Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer

Also Published As

Publication number Publication date
DE3585061D1 (de) 1992-02-13
SE8404283L (sv) 1986-03-01
SE8404283D0 (sv) 1984-08-28
SE455445B (sv) 1988-07-11
JPH0690204B2 (ja) 1994-11-14
EP0173663B1 (de) 1992-01-02
EP0173663A2 (de) 1986-03-05
JPS61116660A (ja) 1986-06-04
EP0173663A3 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
ATE71225T1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
DK2289D0 (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
ATE420175T1 (de) C-typ lektin transmembranantigen, das in menschlichen prostatkrebs exprimiert wird, und deren verwendungen
EP0232871A3 (de) Menschlicher monoklonaler Antikörper, Hybridoma zu seiner Herstellung und seine Verwendung
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
ATE64531T1 (de) Tumortherapeutikum und verfahren zu seiner herstellung.
ES2012997A6 (es) Un procedimiento para la obtencion de una linea de celulas hibridas que producen un anticuerpo monoclonal.
DE3582191D1 (de) Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
ZA884777B (en) Antigen recognized by mca 16 88
ES2121881T3 (es) Anticuerpos monoclonales anti-gangliosidos, su preparacion y su empleo como agente terapeutico de tumores.
ATE84069T1 (de) Murin-hybridoma lym-2 und diagnostikantikoerper, der dadurch hergestellt ist.
NO883040L (no) Middel for undersoekelse av tumorer, samt fremgangsmaate for fremstilling av et slikt middel.
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time